Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cidara Therapeutics (CDTX) Shares Outstanding: 2017-2021

Historic Shares Outstanding for Cidara Therapeutics (CDTX) over the last 5 years, with Dec 2021 value amounting to $67.9 million.

  • Cidara Therapeutics' Shares Outstanding rose 39.86% to $69.2 million in Q2 2022 from the same period last year, while for Jun 2022 it was $69.2 million, marking a year-over-year increase of 39.86%. This contributed to the annual value of $67.9 million for FY2021, which is 51.22% up from last year.
  • According to the latest figures from FY2021, Cidara Therapeutics' Shares Outstanding is $67.9 million, which was up 51.22% from $44.9 million recorded in FY2020.
  • Cidara Therapeutics' Shares Outstanding's 5-year high stood at $67.9 million during FY2021, with a 5-year trough of $20.5 million in FY2017.
  • In the last 3 years, Cidara Therapeutics' Shares Outstanding had a median value of $44.9 million in 2020 and averaged $48.9 million.
  • Data for Cidara Therapeutics' Shares Outstanding shows a peak YoY skyrocketed of 51.22% (in 2021) over the last 5 years.
  • Cidara Therapeutics' Shares Outstanding (Yearly) stood at $20.5 million in 2017, then surged by 35.52% to $27.8 million in 2018, then rose by 21.65% to $33.8 million in 2019, then soared by 32.62% to $44.9 million in 2020, then surged by 51.22% to $67.9 million in 2021.